NCT06239194 2025-06-22Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsModeX Therapeutics, An OPKO Health CompanyPhase 1/2 Recruiting115 enrolled
NCT06006390 2024-08-09CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid TumorsChongqing Precision Biotech Co., LtdPhase 1/2 Recruiting60 enrolled
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled
NCT00041652 2021-08-19Safety Study of hMN14 to Treat Either Colorectal or Breast CancerGilead SciencesPhase 1/2 Completed30 enrolled
NCT01806675 2019-10-0318F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyStanford UniversityPhase 1/2 Completed25 enrolled 14 charts
NCT00003103 2013-07-03Chemotherapy in Treating Patients With Solid TumorsMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed57 enrolled